Prodotti competitors / Area COVID-19 28 giugno 2023 COVID-19: Merck Withdraws EMA Application for LAGEVRIO
Prodotti competitors / Area Onco-Ema 12 giugno 2023 Oncology - CHMP Minutes for the Meeting on 27-30 March 2023
Prodotti competitors / Area Kite, Area Oncology 1 maggio 2023 Europe: Oncology Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023
Prodotti competitors / Area HIV 5 aprile 2023 Raltegravir Viatris: Withdrawal of the marketing authorisation application
Prodotti competitors / Area Oncology, Area COVID-19, Area Kite, Area HIV 31 marzo 2023 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27 - 30 March 2023
Prodotti competitors / Area Kite, Area Onco-Ema 6 marzo 2023 Europe: Oncology CHMP Minutes for December 2022
Prodotti competitors 20 febbraio 2023 Pfizer deposita in EMA la domanda di autorizzazione per elranatamab nel mieloma multiplo
Normativa europea 3 febbraio 2023 A new role for EMA in monitoring and mitigating critical medical device shortages during public health emergencies
Prodotti competitors / Area Kite 31 gennaio 2023 Imbruvica: Withdrawal of the application to change the marketing authorisation
